American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Eloxx Pharmaceuticals, Inc. (ELOX)

$11.94 -0.50% OTC: ELOX · 15-min delayed

ARLINGTON, Massachusetts
Public · OTC: ELOX

Visit website Follow

$0Revenue · FY2025

-$6.0MNet income

ELOXOTC

About Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc. is an American company based in ARLINGTON, Massachusetts.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: ELOX
Headquarters: ARLINGTON, Massachusetts
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: ELOX OTC
SEC CIK: 1035354
EIN: 841368850
SIC: 2836 Biological Products, (No Diagnostic Substances)

Embed this company’s badge

Show Eloxx Pharmaceuticals, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/eloxx-pharmaceuticals-inc/"><img src="https://americancompanies.com/badge/eloxx-pharmaceuticals-inc.svg" alt="Eloxx Pharmaceuticals, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Eloxx Pharmaceuticals, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $0
Net income: -$6.0M
Total assets: $5.3M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

FY2018

FY2019

FY2020

FY2021

FY2022

Revenue Net income

FY 2022

Financial statements

Income statement

Revenue: $0
Operating expenses: $34.4M
Operating income: -$34.4M
Income tax: $0
Net income: -$36.1M
EPS (basic): $-16.65
EPS (diluted): $-16.65

Balance sheet

Total assets: $21.1M
Current assets: $20.1M
Total liabilities: $31.8M
Current liabilities: $23.1M
Shareholders’ equity: -$10.7M

Cash flow

Operating cash flow: -$31.8M
Investing cash flow: -$66.0K
Financing cash flow: $8.8M
Net cash flow: -$23.1M

Statements via Polygon.io (SEC filings)

OTC: ELOX

$11.94 -0.50%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.00 $14.70

52-week range

EPS (diluted): $-16.65
Open: —
Day range: –
Prev close: —
Volume: —

Eloxx Pharmaceuticals, Inc. (ELOX) Stock Price

Reported a net loss of $6.0M in FY2025.
Trading 19% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Eloxx Pharmaceuticals, Inc..

Write a review

Newsroom

News about Eloxx Pharmaceuticals, Inc.

Global Mucopolysaccharidosis Treatment Market to Witness Robust Growth, Projected to Reach USD 5,014.5 Million by 2035 Growing at a CAGR of 5.9% | FMI GlobeNewswire Inc. · 2025-01-02 · positive Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight GlobeNewswire Inc. · 2024-12-19 · positive Eloxx Pharmaceuticals secures $3.2 million in additional funding - Investing.com Investing.com · 2024-07-16 · neutral Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates GlobeNewswire Inc. · 2024-04-16 Eloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013 GlobeNewswire Inc. · 2023-09-07 Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session Benzinga · 2023-08-14

News & sentiment via Polygon.io

FAQ

Eloxx Pharmaceuticals, Inc.: frequently asked questions

Is Eloxx Pharmaceuticals, Inc. an American company?

Eloxx Pharmaceuticals, Inc. is a US-based company headquartered in Arlington, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Eloxx Pharmaceuticals, Inc. headquartered?

Eloxx Pharmaceuticals, Inc. is headquartered in Arlington, Massachusetts, United States.

Is Eloxx Pharmaceuticals, Inc. publicly traded?

Yes — Eloxx Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ELOX on the OTC.

What does Eloxx Pharmaceuticals, Inc. do?

Eloxx Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore